|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common stock, par value (in dollars per share) | ||||||||||||||||||||
| Common stock, authorized (in shares) | ||||||||||||||||||||
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits in financial institutions and federal funds sold | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Interest-bearing time deposits | ||||||||||||||||||||
| Securities available-for-sale | ||||||||||||||||||||
| Federal Home Loan Bank (FHLB) and Federal Reserve Bank (FRB) stock, at cost | ||||||||||||||||||||
| Loans receivable, net | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Bank premises and equipment, net | ||||||||||||||||||||
| Accrued income receivable | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Noninterest-bearing checking | ||||||||||||||||||||
| Interest-bearing checking | ||||||||||||||||||||
| Savings and money market | ||||||||||||||||||||
| Time, $250 and over | ||||||||||||||||||||
| Other time | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Securities sold under agreements to repurchase | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Common stock, $2 par value, authorized 18,000,000 shares; issued and outstanding 8,857,220 shares as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive (loss) | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
